Tony Davis

Advisor, Investor, Non Exec Director, Chair

📍 Australia🔄 Updated September 2026💼 3 investments📅 10 years investing🗓 Last invested Jul 2022
Angel investor🌍 Australia
3
Total investments
1
Early stage
1
Mid stage
1
Late stage
10y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Advisor, investor
Jul 2022
Prospection pioneers patient-centric intelligence, illuminating patient care’s impact on market share for pharmaceutical brands. Prospections proprietary knowledge engine, the Patient-centric Intelligence Core, powers AI-forward products, services, and enriched data offerings to help commercial, medical, and analytics teams optimize drug performance and improve patient outcomes. For more than a decade, Prospection has worked across 20+ therapeutic areas and 100+ indications, and has been the patient-centric intelligence partner of choice for more than 100 life sciences companies.
Advisor, investor
Jul 2019
ParaFlare is joining Deloitte Australia from 1 February 2024. Our team will continue to provide the highest level of cyber protection to our customers under the Deloitte brand. We specialise in managed detection and response - which is 24/7 cyber protection for businesses. To find out more about our services, visit www.paraflare.com
Advisor, investor
2016
Streem delivers a complete media intelligence solution backed by local experts who care. Featuring realtime media monitoring, in-depth analytics and reporting, social listening, and press release distribution - in a single platform.
Experience · 3 entries
All (3)
Investments (3)
2022
Advisor, investor
Jul 2022
Prospection pioneers patient-centric intelligence, illuminating patient care’s impact on market share for pharmaceutical brands. Prospections proprietary knowledge engine, the Patient-centric Intelligence Core, powers AI-forward products, services, and enriched data offerings to help commercial, medical, and analytics teams optimize drug performance and improve patient outcomes. For more than a decade, Prospection has worked across 20+ therapeutic areas and 100+ indications, and has been the patient-centric intelligence partner of choice for more than 100 life sciences companies.
2019
Advisor, investor
Jul 2019
ParaFlare is joining Deloitte Australia from 1 February 2024. Our team will continue to provide the highest level of cyber protection to our customers under the Deloitte brand. We specialise in managed detection and response - which is 24/7 cyber protection for businesses. To find out more about our services, visit www.paraflare.com
2016
Advisor, investor
2016
Streem delivers a complete media intelligence solution backed by local experts who care. Featuring realtime media monitoring, in-depth analytics and reporting, social listening, and press release distribution - in a single platform.
Investment activity
2016–2022 · 3 investments
201612019120221
Recent (last 2 years)Earlier